Company Profiles

driven by the PitchBook Platform

AMURA

Description

Developer of protease inhibitors. The company operates a drug discovery business specializing in diseases such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain and malaria.

2005

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

5

Investors

Description

Developer of protease inhibitors. The company operates a drug discovery business specializing in diseases such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain and malaria.

Website:

www.amura.co.uk

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Healthcare Technology Systems

Primary Office

Highfield Court Church Lane, Madingley Cambridgeshire CB23 8AGEngland +44 (0)19 5421 1515
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AMURA's full profile, request a free trial.

AMURA Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AMURA Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Avlar BioVenturesVenture CapitalMinority000 0000000 0000
BeringeaPE/BuyoutMinority000 0000000 0000
Noble Fund ManagersInvestment BankMinority000 0000000 0000
Sitka PartnersVenture CapitalMinority000 0000000 0000
Touchstone InnovationsVenture CapitalMinority000 0000000 0000
Avlar BioVentures Venture Capital
Beringea PE/Buyout
Noble Fund Managers Investment Bank
Sitka Partners Venture Capital
Touchstone Innovations Venture Capital

AMURA Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Nick FlinnHead of Preclinical Development
Daniel Roach Ph.DBoard Member & General Manager
David Brown Ph.DExecutive Chairman
Nick Flinn Head of Preclinical Development
Daniel Roach Ph.D Board Member & General Manager
David Brown Ph.D Executive Chairman

AMURA Board Members (4)

NameRepresentingRoleSinceContact
Info
Alan GoodmanAvlar BioVenturesChief Executive Officer & Director, Finance000 0000
Daniel Roach Ph.DSelfBoard Member & General Manager000 0000
David Brown Ph.DSelfExecutive Chairman000 0000
Steven TuckleyBeringeaChief Financial Officer000 0000
Alan Goodman Chief Executive Officer & Director, Finance Avlar BioVentures
Daniel Roach Ph.D Board Member & General Manager Self
David Brown Ph.D Executive Chairman Self
Steven Tuckley Chief Financial Officer Beringea
Request full access to PitchBook